AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
INTERACTIVE EFFECTS OF SUBANESTHETIC KETAMINE AND SUBHYPNOTIC LORAZEPAM IN HUMANS
Authors: KRYSTAL JH KARPER LP BENNETT A DSOUZA DC ABIDARGHAM A MORRISSEY K ABISAAB D BREMNER JD BOWERS MB SUCKOW RF STETSON P HENINGER GR CHARNEY DS
Citation: Jh. Krystal et al., INTERACTIVE EFFECTS OF SUBANESTHETIC KETAMINE AND SUBHYPNOTIC LORAZEPAM IN HUMANS, Psychopharmacology, 135(3), 1998, pp. 213-229
CHANGES OF BENZODIAZEPINE RECEPTOR AND DEVELOPMENT OF TOLERANCE DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS
Authors: FUJITA M WOODS SW VERHOEFF NP ABIDARGHAM A SOARES JC JATLOW PA BALDWIN RM ZOGHBI SS SEIBYL JP RAJEEVAN N KRYSTAL JH INNIS RB
Citation: M. Fujita et al., CHANGES OF BENZODIAZEPINE RECEPTOR AND DEVELOPMENT OF TOLERANCE DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS, The Journal of nuclear medicine, 39(5), 1998, pp. 41-41
PET STUDIES OF BINDING COMPETITION BETWEEN ENDOGENOUS DOPAMINE AND THE D-1 RADIOTRACER [C-11] NNC-756
Authors: ABIDARGHAM A SIMPSON N KEGELES L PARSEY R HWANG DR ANJILVEL S ZEAPONCE Y LOMBARDO I VANHEERTUM R FOGED C HALLDIN C LARUELLE M
Citation: A. Abidargham et al., PET STUDIES OF BINDING COMPETITION BETWEEN ENDOGENOUS DOPAMINE AND THE D-1 RADIOTRACER [C-11] NNC-756, The Journal of nuclear medicine, 39(5), 1998, pp. 209-209
SPECT IMAGING OF RESTING DOPAMINE SYNAPTIC RELEASE IN THE STRIATUM OFUNTREATED SCHIZOPHRENIC-PATIENTS
Authors: ABIDARGHAM A PRINTZ D KEGELES L RODENHISER J ZEAPONCE Y WEISS R POZNIAKOFF T GERMAN J VANHEERTUM R LARUELLE M
Citation: A. Abidargham et al., SPECT IMAGING OF RESTING DOPAMINE SYNAPTIC RELEASE IN THE STRIATUM OFUNTREATED SCHIZOPHRENIC-PATIENTS, The Journal of nuclear medicine, 39(5), 1998, pp. 316-316
BENZODIAZEPINE RECEPTOR IMAGING USING [I-123] IOMAZENIL SPECT IN SCHIZOPHRENIA
Authors: VERHOEFF NPLG SOARES JC DSOUZA CD GIL R DEGEN K WEXLER B ABIDARGHAM A BALDWIN RM ZOGHBI SS FUJITA M RAJEEVAN N SEIBYL JP KRYSTAL JH INNIS RB
Citation: Nplg. Verhoeff et al., BENZODIAZEPINE RECEPTOR IMAGING USING [I-123] IOMAZENIL SPECT IN SCHIZOPHRENIA, The Journal of nuclear medicine, 39(5), 1998, pp. 317-317
REPRODUCIBILITY OF SPECT MEASUREMENT OF STRIATAL AMPHETAMINE-INDUCED DOPAMINE RELEASE IN HEALTHY-SUBJECTS
Authors: KEGELES L ZEAPONCE Y ABIDARGHAM A RODENHISER J WANG T KEILP J WEISS R COOPER TB VANHEERTUM R LARUELLE M
Citation: L. Kegeles et al., REPRODUCIBILITY OF SPECT MEASUREMENT OF STRIATAL AMPHETAMINE-INDUCED DOPAMINE RELEASE IN HEALTHY-SUBJECTS, The Journal of nuclear medicine, 39(5), 1998, pp. 925-925
INCREASED STRIATAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA - CONFIRMATION IN A 2ND COHORT
Authors: ABIDARGHAM A GIL R KRYSTAL J BALDWIN RM SEIBYL JP BOWERS M VANDYCK CH CHARNEY DS INNIS RB LARUELLE M
Citation: A. Abidargham et al., INCREASED STRIATAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA - CONFIRMATION IN A 2ND COHORT, The American journal of psychiatry, 155(6), 1998, pp. 761-767
ALTERATIONS OF BENZODIAZEPINE RECEPTORS IN TYPE-II ALCOHOLIC SUBJECTSMEASURED WITH SPECT AND [I-123] IOMAZENIL
Authors: ABIDARGHAM A KRYSTAL JH ANJILVEL S SCANLEY BE ZOGHBI S BALDWIN RM RAJEEVAN N ELLIS S PETRAKIS IL SEIBYL JP CHARNEY DS LARUELLE M INNIS RB
Citation: A. Abidargham et al., ALTERATIONS OF BENZODIAZEPINE RECEPTORS IN TYPE-II ALCOHOLIC SUBJECTSMEASURED WITH SPECT AND [I-123] IOMAZENIL, The American journal of psychiatry, 155(11), 1998, pp. 1550-1555
BENZODIAZEPINE RECEPTOR ANTAGONISTS - POSSIBLE USES IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
Authors: ABIDARGHAM A CHARNEY DS KRYSTAL JH
Citation: A. Abidargham et al., BENZODIAZEPINE RECEPTOR ANTAGONISTS - POSSIBLE USES IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS, CNS DRUGS, 8(3), 1997, pp. 244-256
SPECT MEASUREMENT OF HUMAN STRIATAL SYNAPTIC DOPAMINE CONCENTRATION WITH [I-123] IBZM
Authors: ABIDARGHAM A KEGELES L MALASPINA D CLARK S GORMAN J MANN J VANHEERTUM R LARUELLE M
Citation: A. Abidargham et al., SPECT MEASUREMENT OF HUMAN STRIATAL SYNAPTIC DOPAMINE CONCENTRATION WITH [I-123] IBZM, Schizophrenia research, 24(1-2), 1997, pp. 175-175
IN-VIVO EVALUATION OF DOPAMINE SYNAPTIC FUNCTION IN UNTREATED SCHIZOPHRENIC-PATIENTS
Authors: LARUELLE M ABIDARGHAM A KRYSTAL JH CHARNEY DS INNIS RB
Citation: M. Laruelle et al., IN-VIVO EVALUATION OF DOPAMINE SYNAPTIC FUNCTION IN UNTREATED SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 179-179
THE ROLE OF SEROTONIN IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA
Authors: ABIDARGHAM A LARUELLE M AGHAJANIAN GK CHARNEY D KRYSTAL J
Citation: A. Abidargham et al., THE ROLE OF SEROTONIN IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA, The Journal of neuropsychiatry and clinical neurosciences, 9(1), 1997, pp. 1-17
IMAGING D-2 RECEPTOR OCCUPANCY BY ENDOGENOUS DOPAMINE IN HUMANS
Authors: LARUELLE M DSOUZA CD BALDWIN RM ABIDARGHAM A KANES SJ FINGADO CL SEIBYL JP ZOGHBI SS BOWERS MB JATLOW P CHARNEY DS INNIS RB
Citation: M. Laruelle et al., IMAGING D-2 RECEPTOR OCCUPANCY BY ENDOGENOUS DOPAMINE IN HUMANS, Neuropsychopharmacology, 17(3), 1997, pp. 162-174
HUMAN BIODISTRIBUTION AND DOSIMETRY OF IODINE-123-FLUOUOALKYL ANALOGSOF BETA-CIT
Authors: ABIDARGHAM A INNIS RB WISNIEWSKI G BALDWIN RM NEUMEYER JL SEIBYL JP
Citation: A. Abidargham et al., HUMAN BIODISTRIBUTION AND DOSIMETRY OF IODINE-123-FLUOUOALKYL ANALOGSOF BETA-CIT, European journal of nuclear medicine, 24(11), 1997, pp. 1422-1425
CHANGE OF BENZODIAZEPINE RECEPTOR DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS
Authors: FUJITA M WOODS SW ABIDARGHAM A JATLOW P BALDWIN RM ZOGHBI SS SEIBYL JP RAJEEVAN N WHITE JA KRYSTAL JH INNIS RB
Citation: M. Fujita et al., CHANGE OF BENZODIAZEPINE RECEPTOR DURING CHRONIC BENZODIAZEPINE ADMINISTRATION IN HEALTHY-HUMAN SUBJECTS, The Journal of nuclear medicine, 38(5), 1997, pp. 173-173
IMPACT OF THE CHOICE OF OUTCOME MEASURE ON THE SPECT MEASUREMENT OF D2 RECEPTORS IN SCHIZOPHRENIA
Authors: LARUELLE M ABIDARGHAM A GIL R KRYSTAL J SEIBYL J BALDWIN R INNIS RB
Citation: M. Laruelle et al., IMPACT OF THE CHOICE OF OUTCOME MEASURE ON THE SPECT MEASUREMENT OF D2 RECEPTORS IN SCHIZOPHRENIA, The Journal of nuclear medicine, 38(5), 1997, pp. 351-351
PRECLINICAL EVALUATION OF [I-123] R93274 AS A SPECT RADIOTRACER FOR IMAGING 5-HT2A RECEPTORS
Authors: ABIDARGHAM A ZEAPONCE Y TERRIER D ALTIKRITI M BALDWIN RM HOFFER P CHARNEY D LEYSEN JE LARUELLE M MERTENS J INNIS RB
Citation: A. Abidargham et al., PRECLINICAL EVALUATION OF [I-123] R93274 AS A SPECT RADIOTRACER FOR IMAGING 5-HT2A RECEPTORS, European journal of pharmacology, 321(3), 1997, pp. 285-293
SPECT IMAGING OF SYNAPTIC DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS - AN EXPERIMENTAL VALIDATION OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA
Authors: LARUELLE M ABIDARGHAM A GIL R VANDYCK CH ERDOS J DSOUZA D ROSENBLATT W MCCANCEKATZ E ZEAPONCE Y ZOGHBI SS BALDWIN RM HOFFER PB KRYSTAL J CHARNEY DS INNIS RB
Citation: M. Laruelle et al., SPECT IMAGING OF SYNAPTIC DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS - AN EXPERIMENTAL VALIDATION OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, p.
SPECT IMAGING OF DOPAMINE TRANSPORTERS IN HUMAN BRAIN WITH IODINE-123-FLUOROALKYL ANALOGS OF BETA-CIT
Authors: ABIDARGHAM A GANDELMAN MS DEERAUSQUIN GA ZEAPONCE Y ZOGHBI SS BALDWIN RM LARUELLE M CHARNEY DS HOFFER PB NEUMEYER JL INNIS RB
Citation: A. Abidargham et al., SPECT IMAGING OF DOPAMINE TRANSPORTERS IN HUMAN BRAIN WITH IODINE-123-FLUOROALKYL ANALOGS OF BETA-CIT, The Journal of nuclear medicine, 37(7), 1996, pp. 1129-1133
SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN SCHIZOPHRENIA
Authors: LARUELLE M ABIDARGHAM A GIL R ERDOS J DSOUZA CD ZOGHBI SS BALDWIN RM SEIBYL JP KRYSTAL J CHARNEY DS INNIS RB
Citation: M. Laruelle et al., SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN SCHIZOPHRENIA, The Journal of nuclear medicine, 37(5), 1996, pp. 121-121
AGE-RELATED DECLINE IN AMPHETAMINE-INDUCED DOPAMINE RELEASE MEASURED WITH SPECT AND [123I]IBZM IN HEALTHY-SUBJECTS
Authors: LARUELLE M VANDYCK CH ABIDARGHAM A ROSENBLATT W ZOGHBI SS BALDWIN RM HOFFER PB CHARNEY DS INNIS RB
Citation: M. Laruelle et al., AGE-RELATED DECLINE IN AMPHETAMINE-INDUCED DOPAMINE RELEASE MEASURED WITH SPECT AND [123I]IBZM IN HEALTHY-SUBJECTS, The Journal of nuclear medicine, 37(5), 1996, pp. 124-124
SPECT IMAGING OF BENZODIAZEPINE RECEPTORS IN ALCOHOLICS AND HEALTHY CONTROLS
Authors: ABIDARGHAM A KRYSTAL J WEBB E ZOGHBI S LARUELLE M PETRAKIS I BALDWIN RM HOFFER PB CHARNEY DS INNIS RB
Citation: A. Abidargham et al., SPECT IMAGING OF BENZODIAZEPINE RECEPTORS IN ALCOHOLICS AND HEALTHY CONTROLS, The Journal of nuclear medicine, 37(5), 1996, pp. 1273-1273
SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY IMAGING OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS
Authors: LARUELLE M ABIDARGHAM A VANDYCK CH GIL R DSOUZA CD ERDOS J MCCANCE E ROSENBLATT W FINGADO C ZOGHBI SS BALDWIN RM SEIBYL JP KRYSTAL JH CHARNEY DS INNIS RB
Citation: M. Laruelle et al., SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY IMAGING OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 9235-9240
SEROTONIN AND SCHIZOPHRENIA - A REVIEW
Authors: ABIDARGHAM A LARUELLE M CHARNEY D KRYSTAL J
Citation: A. Abidargham et al., SEROTONIN AND SCHIZOPHRENIA - A REVIEW, Medicamentos de actualidad, 32(2), 1996, pp. 171-185
INCREASED STRIATAL DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS
Authors: LARUELLE M ABIDARGHAM A VANDYCK CH KRYSTAL JH CHARNEY DS INNIS RB
Citation: M. Laruelle et al., INCREASED STRIATAL DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS, Biological psychiatry, 39(7), 1996, pp. 208-208
Risultati: 1-25 | 26-50 | 51-52